BAY-U-3405 INHIBITS CEREBRAL VASOSPASM INDUCED BY AUTHENTIC THROMBOXANE-A2

被引：0
|
作者：
BRAUN, M
SCHROR, K
机构：
来源：
STROKE | 1990年 / 21卷 / 12期
关键词：
CEREBRAL VASOSPASM; THROMBOXANE-A2;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Platelet activation results in the formation of various vasoactive mediators such as thromboxane A2 and serotonin. We investigated the effects of Bay U 3405 [(3R)-3-(4-fluorophenyl-sulfonamido)-1,2,3,4,-tetrahydro-9-carbazolepropanoic acid] on vasocontractions of isolated bovine cerebral arteries induced by U 46.619, a stable thromboxane/prostaglandin-endoperoxide analogue, and authentic thromboxane A2 released from thrombin-stimulated human platelets. Bay U 3405 (0.001-10 mu-mol/1) potently inhibited the contraction induced by U 46.619 and demonstrated a reduction of the thromboxane-mediated component of platelet-induced contractile response at higher concentrations (0.1-10 mu-mol).
引用
收藏
页码：152 / 154
页数：3
相关论文
共 50 条
  • [41] MYOCARDIAL-INFARCTION EXPERIMENTALLY INDUCED BY THROMBOXANE-A2
    SHIMAMOTO, T
    KOBAYASHI, M
    TAKAHASHI, T
    NUMANO, F
    MOROOKA, S
    CIRCULATION, 1977, 56 (04) : 123 - 123
  • [42] MECHANISM OF CORONARY VASOCONSTRICTION INDUCED BY CARBOCYCLIC THROMBOXANE-A2
    SMITH, EF
    LEFER, AM
    NICOLAOU, KC
    AMERICAN JOURNAL OF PHYSIOLOGY, 1981, 240 (04): : H493 - H497
  • [43] RIDOGREL INHIBITS SYSTEMIC AND RENAL FORMATION OF THROMBOXANE-A2 AND ANTAGONIZES PLATELET THROMBOXANE-A2 PROSTAGLANDIN ENDOPEROXIDE RECEPTORS UPON CHRONIC ADMINISTRATION TO MAN
    WEBER, C
    BEETENS, JR
    TEGTMEIER, F
    VANROOY, P
    VERCAMMEN, E
    WOUTERS, L
    DECLERCK, F
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (02) : 214 - 220
  • [44] THE EFFECTS OF AN ORAL THROMBOXANE TP RECEPTOR ANTAGONIST BAY U-3405, ON PROSTAGLANDIN D2-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ASTHMA, AND RELATIONSHIP TO PLASMA DRUG CONCENTRATIONS
    JOHNSTON, SL
    BARDIN, PG
    HARRISON, J
    RITTER, W
    JOUBERT, JR
    HOLGATE, ST
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (05) : 402 - 408
  • [45] EFFECT OF INTRACISTERNAL THROMBOXANE-A2 ANALOG ON CEREBRAL-ARTERY PERMEABILITY
    ZUCCARELLO, M
    SASAKI, T
    KASSELL, NF
    YAMASHITA, M
    ACTA NEUROCHIRURGICA, 1988, 90 (3-4) : 144 - 151
  • [46] VASCULAR TONE AND THROMBOXANE-A2 LEVEL IN CANINE CEREBRAL-ARTERIES
    FUJIWARA, M
    SHIRAHASE, H
    USUI, H
    KURAHASHI, K
    BLOOD VESSELS, 1987, 24 (03): : 167 - 168
  • [47] EFFECT OF A NEW THROMBOXANE ANTAGONIST, BAY U-3405, ON PLATELET-FUNCTION IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    RIAMBAU, V
    DECASTELLARNAU, C
    GARCIA, C
    GONZALEZ, O
    ALBORS, M
    VIVER, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1321 - 1321
  • [48] HEMORRHAGE AND INTRACRANIAL HYPERTENSION IN COMBINATION INCREASE CEREBRAL PRODUCTION OF THROMBOXANE-A2
    KONG, DL
    PROUGH, DS
    WHITLEY, JM
    TAYLOR, C
    VINES, S
    DEAL, DD
    DEWITT, DS
    CRITICAL CARE MEDICINE, 1991, 19 (04) : 532 - 538
  • [49] U46619, A THROMBOXANE-A2 AGONIST, INHIBITS KCA CHANNEL ACTIVITY FROM PIG CORONARY-ARTERY
    SCORNIK, FS
    TORO, L
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03): : C708 - C713
  • [50] SYNTHESIS AND INHIBITORY ACTIVITY OF ISOINDOLINONE DERIVATIVES ON THROMBOXANE-A2 ANALOG (U-46619)-INDUCED VASOCONTRACTION
    KATO, Y
    EBIIKE, H
    ACHIWA, K
    ASHIZAWA, N
    KURIHARA, T
    KOBAYASHI, F
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (07) : 2060 - 2062
12345